Hemrajani Rekha's Form 4 filing
Maxcyte, Inc. (MXCT) · filed Aug 27, 2025
- Accession no.
- 0000905148-25-003155
- Filed
- Aug 27, 2025
- Trade date
- Jun 25, 2025
- Filing delay
- 63 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $22.3K. It was filed 63 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hemrajani RekhaCIK 0001771213 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | Common Stock | SSaleDisposed | −10,684 | $2.09 | −$22,329.56 | 39,893 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.